Abstract
Value in healthcare can be defined as providing the optimal outcome per health dollar spent. Improving the value of healthcare for patients and healthcare organizations requires an understanding and evaluation of the costs and benefits. Investing in quality improvement (QI) work can bring about financial results for healthcare organizations over time, have beneficial organizational effects, and improve outcomes for patients. This article continues a series of QI educational papers in the Journal of Perinatology, and reviews financial and economic measures used to create the business case for QI. Ultimately, the business case for QI is better defined as a business strategy for success.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Institute of Medicine (US). Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001.
Berwick DM. A user’s manual for the IOM’s ‘Quality Chasm’ report. Health Aff. 2002;21:80–90.
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff. 2008;27:759–69.
Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston, MA: Harvard Business School Press; 2006.
Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–81.
Kohn LT, Corrigan J, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
Brooks RH. The end of the quality improvement movement: long live improving value. JAMA. 2010;304:1831–2.
Øvretveit J. Does improving quality save money? A review of evidence of which improvements to quality reduce costs to health service providers. London: The Health Foundation; 2009.
Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med. 2009;361:109–12.
Swanson JR, Pearlman SA. Roadmap to a successful quality improvement project. J Perinatol. 2017;37:112–5.
Katakam L, Suresh GK. Identifying a quality improvement project. J Perinatol. 2017;37:1161–5.
Picarillo AP. Introduction to quality improvement tools for the clinician. J Perinatol. 2018;38:929–35.
Coughlin K, Posencheg MA. Quality improvement methods—part II. J Perinatol. 2019;39:1000–7.
Gupta M, Kaplan HC. Measurement for quality improvement: using data to drive change. J Perinatol. 2020. https://doi.org/10.1038/s41372-019-0572-x.
Boehler R, Hardesty D, Gonzales E, Kasnetz K. The business case for quality. Health Financ Manag. 2009;63:62–6.
Homer C, Child Health Business Case Working Group. Exploring the business case for improving the quality of health care for children. Health Aff. 2004;23:159–66.
Shah A, Course S. Building the business case for quality improvement: a framework for evaluating return on investment. Future Health J. 2018;5:132–7.
Leatherman S, Berwick D, Iles D, Lewin LS, Davidoff F, Nolan T, et al. The business case for quality: case studies and an analysis. Health Aff. 2003;22:17–30.
Crawley-Stout LA, Ward KA, See CH, Randolph G. Lessons learned from measuring return on investment in public health quality improvement initiatives. J Public Health Manag Pr. 2016;22:E28–37.
Fisher D, Cochran KM, Provost LP, Patterson J, Bristol T, Metzguer K, et al. Reducing central line-associated bloodstream infections in North Carolina NICUs. Pediatrics. 2013;132:e1664–71.
Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003;12:366–71.
Thompson C, Pulleyblank R, Parrott S, Essex H. The cost-effectiveness of quality improvement projects: a conceptual framework, checklist and online tool for considering the costs and consequences of implementation-based quality improvement. J Eval Clin Pract. 2016;22:26–30.
Steele C, Czerwin A, Bixby C. Breast milk bar code scanning results in time savings and staff efficiency. J Acad Nutr Diet. 2015;115:23–6.
Oza-Frank R, Kachoria R, Dail J, Green J, Walls K, McClead RE Jr. A quality improvement project to decrease human milk errors in the NICU. Pediatrics. 2017;139:2.
Agency for Healthcare Research and Quality. Toolkit for using the AHRQ quality indicators. 2017. https://www.ahrq.gov/patient-safety/settings/hospital/resource/qitool/index.html.
Robert Wood Johnson Foundation. Welcome to the ROI forecasting calculator. 2007. https://www.rwjf.org/en/library/research/2007/01/welcome-to-the-roi-forecasting-calculator.html.
Center for Health Care Strategies. Welcome to the ROI forecasting calculator. 2007. http://www.chcsroi.org/.
Center for Health Care Strategies. The medicaid return on investment template. 2007. https://www.chcs.org/resource/the-medicaid-return-on-investment-template/.
Brousselle A, Benmarhnia T, Benhadj L. What are the benefits and risks of using return on investment to defend public health programs? Prev Med Rep. 2016;3:135–8.
Rogowski JA, Horbar JD, Plsek PE, Baker LS, Deterding J, Edwards WH, et al. Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics. 2001;107:23–9.
McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science. Pharmacoeconomics. 1999;15:357–67.
The American Board of Pediatrics. Newborn screening for critical congenital heart disease performance improvement module. 2020. https://cont-certification.abp.org/moc/moc-dashboard/moc-activities/quality-improvement/online-improvement-activities/activity-details/4046.
Hoffman JI. It is time for routine neonatal screening by pulse oximetry. Neonatology. 2011;99:1–9.
Carias C, Chesson HW, Grosse SD, Li R, Meltzer MI, Miller GF, et al. Recommendations of the second panel on cost effectiveness in health and medicine: a reference, not a rule book. Am J Prev Med. 2018;54:600–2.
Huang L, Roberts CT, Manley BJ, Owen LS, Davis PG, Dalziel KM. Cost-effectiveness analysis of nasal continuous positive airway pressure versus nasal high flow therapy as primary support for infants born preterm. J Pediatr. 2018;196:58–64.e52.
Yieh L, Dukhovny D, Zhou CG, Gievers L, Caughey AB. Cost effectiveness of neonatal resuscitation at 22 weeks of gestation. Obstet Gynecol. 2019;133:1199–207.
Sanchez-Luna M, Burgos-Pol R, Oyaguez I, Figueras-Aloy J, Sanchez-Solis M, Martinon-Torres F, et al. Cost-utility analysis of palivizumab for respiratory syncytial virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain. BMC Infect Dis. 2017;17:687.
Dukhovny D, Zupancic JAF. Economic evaluation with clinical trials in neonatology. NeoReviews. 2011;12:e69–75.
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–8.
Dukhovny D, Pursley DM, Kirpalani HM, Horbar JH, Zupancic JA. Evidence, quality, and waste: solving the value equation in neonatology. Pediatrics. 2016;137:e20150312.
Ho T, Zupancic JAF, Pursley DM, Dukhovny D. Improving value in neonatal intensive care. Clin Perinatol. 2017;44:617–25.
Swensen SJ, Dilling JA, Mc Carty PM, Bolton JW, Harper CM Jr. The business case for health-care quality improvement. J Patient Saf. 2013;9:44–52.
In: Donaldson MS (ed). Statement on quality of care. Washington, DC: National Academies Press; 1998.
Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line-associated bloodstream infections. Pediatrics. 2014;133:e1525–32.
Padula WV, Lee KKH, Pronovost PJ. Using economic evaluation to illustrate value of care for improving patient safety and quality: choosing the right method. J Patient Saf. 2017. https://doi.org/10.1097/PTS.0000000000000410. [Epub ahead of print].
Gross PA, Ferguson JP, DeMauro P, Hogstrom H, Garrett R, Cima L, et al. The business case for quality at a university teaching hospital. Jt Comm J Qual Patient Saf. 2007;33:163–70.
Adirim T, Meade K, Mistry K. AAP COUNCIL ON QUALITY IMPROVEMENT AND PATIENT SAFETY. A New Era in Quality Measurement: The Development and Application of Quality Measures. Pediatrics. 2017;139:e20163442.
Weeks WB, Resar R. Does reducing length of stay make a business case? Jt Comm J Qual Patient Saf. 2008;34:627–8.
Conway PH. Value-driven health care: implications for hospitals and hospitalists. J Hosp Med. 2009;4:507–11.
Main EK. New perinatal quality measures from the National Quality Forum, the Joint Commission and The Leapfrog Group. Curr Opin Obstet Gynecol. 2009;21:532–40.
The Leapfrog Group. The Leapfrog Group: who we are. 2019. https://www.leapfroggroup.org.
The Leapfrog Group. The leapfrog hospital survey scoring algorithms: scoring details for sections 2-10 of the 2019 Leapfrog Hospital Survey. Washington DC: The Leapfrog Group; 2019.
U.S. News & World Report. U.S. News & World Report Hospital Rankings & Ratings. 2019. https://health.usnews.com/best-hospitals.
Olmsted MG, Powell R, Murphy J, Bell D, Stanley M, Sanchez R. Methodology: U.S. News & World Report best children’s hospitals 2019-20. Durham, North Carolina: RTI International; 2019.
Kaplan RS, Anderson SR. Time-driven activity-based costing: a simpler and more powerful path to higher profits. Boston: Harvard Business School Press; 2007.
Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89:46–52.
Keel G, Savage C, Rafiq M, Mazzocato P. Time-driven activity-based costing in health care: a systematic review of the literature. Health Policy. 2017;121:755–63.
Popat K, Gracia KA, Guzman AB, Feeley TW. Using time-driven activity-based costing to model the costs of various process-improvement strategies in acute pain management. J Health Manag. 2018;63:e76–85.
Scoville R, Little K. Comparing lean and quality improvement. Cambridge, Massachusetts: Institute for Healthcare Improvement; 2014.
Author information
Authors and Affiliations
Contributions
HRF and SDD created the outline, wrote the draft, and approved the final version of the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fischer, H.R., Duncan, S.D. The business case for quality improvement. J Perinatol 40, 972–979 (2020). https://doi.org/10.1038/s41372-020-0660-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-020-0660-y
This article is cited by
-
How is return on investment from quality improvement programmes conceptualised by mental healthcare leaders and why: a qualitative study
BMC Health Services Research (2023)
-
Identifying and understanding benefits associated with return-on-investment from large-scale healthcare Quality Improvement programmes: an integrative systematic literature review
BMC Health Services Research (2022)
-
The development of the concept of return-on-investment from large-scale quality improvement programmes in healthcare: an integrative systematic literature review
BMC Health Services Research (2022)
-
Advancements in neonatology through quality improvement
Journal of Perinatology (2022)
-
A practical guide to publishing a quality improvement paper
Journal of Perinatology (2021)